logo
Worldwide Peptide Therapeutics Industry to 2028 - Rising Geriatric Population, Increasing Prevalence of Cancer and Technological Advancements are Driving Growth - ResearchAndMarkets.com

Worldwide Peptide Therapeutics Industry to 2028 - Rising Geriatric Population, Increasing Prevalence of Cancer and Technological Advancements are Driving Growth - ResearchAndMarkets.com

By AP News
Published - Sep 22, 2022, 05:39 AM ET
Last Updated - Jun 24, 2023, 08:02 AM EDT

DUBLIN--(BUSINESS WIRE)--Sep 22, 2022--

The "Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global peptide therapeutics market is expected to grow at a CAGR of around 9.5% during 2022-2028. This report on global peptide therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global peptide therapeutics market by segmenting the market based on type, manufacturer, synthesis technology, routes of administration, application and region. Also, detailed profiles of companies operating in the peptide therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Companies Mentioned

  • Amgen Inc.
  • Apitope International NV
  • Arch Biopartners Inc.
  • AstraZeneca plc
  • Circle Pharma Inc.
  • Corden Pharma GmbH
  • F. Hoffmann-La Roche AG
  • Ipsen Group
  • Lonza Group AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Zealand Pharma A/S

Market Dynamics

Drivers

  • Rising Geriatric Population
  • Increasing Prevalence of Cancer
  • Technological Advancements

Challenges

  • Poor Chemical and Physical Stability
  • Presence of Stringent Safety Regulations

Historical & Forecast Period

  • Base Year: 2021
  • Historical Period: 2017-2020
  • Forecast Period: 2022-2028

Market by Type

  • Innovative
  • Generic

Market by Type by Manufacturer

  • Outsourced
  • In-house

Market by Synthesis Technology

  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology

Market by Routes of Administration

  • Parenteral
  • Oral
  • Others

Market by Routes of Application

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Others

Market by Region

  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Rest of Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/ipzju6

View source version on businesswire.com:https://www.businesswire.com/news/home/20220922005462/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: SENIORS CONSUMER HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024